Princess Margaret Cancer Center at University Health Network-led researchers constructed a detailed single-cell atlas of ...

The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...

Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...

A new study finds that statin use significantly improves survival outcomes in patients with chronic lymphocytic leukemia or ...

Tyrosine kinase inhibitor maintenance therapy after stem cell transplantation for FLT3-mutated acute myeloid leukemia (Protocol). Cochrane Database of Systematic Reviews 2025, Issue 4. Art. No.: ...

and encouraging initial antitumor activity in patients with KRAS G12D mutant non-small cell lung cancer (NSCLC). The objective response rate for zoldonrasib was reported at 61%, with a disease ...

This analysis looked at three cohorts: patients who had tumors with mutations in the tyrosine kinase domain (Cohort 1), people with the same type of mutation who previously received both platinum ...